Gene expression and metastasis of somatic cell hybrids between murine fibroblast cell lines of different malignant potential.

Autor: Tuck AB; London Regional Cancer Centre, Ontario, Canada., Wilson SM, Sergovich FR, Chambers AF
Jazyk: angličtina
Zdroj: Somatic cell and molecular genetics [Somat Cell Mol Genet] 1991 Jul; Vol. 17 (4), pp. 377-89.
DOI: 10.1007/BF01233063
Abstrakt: We have used somatic cell hybrids to study the relationship between ras sensitivity, metastasis, and the expression of ras-responsive or "metastasis-associated" genes. We have previously shown that NIH 3T3 cells are nontumorigenic, but are made metastatic by transfection and expression of activated ras (i.e., they are ras-sensitive). LTA cells, however, are initially tumorigenic, but nonmetastatic, and are not altered in malignancy by ras (i.e., they are ras-resistant). We also have shown that patterns of expression of ras-responsive and "metastasis-associated" genes differ markedly between these two cell types. In the present work, we have constructed three sets of somatic cell hybrids: NIH 3T3 X LTA cells (designated NL), NIH 3T3 X ras-transfected LTA cells (designated NLR), and LTA X ras-transfected NIH 3T3 cells (designated LNR). In all three sets of cell hybrids, pooled clones were found to be highly metastatic in the chick embryo assay, suggesting complementation had occurred. Those cell hybrids that contained ras (NLR and LNR hybrids) were significantly more metastatic than those that did not (NL hybrids). Selected clones of low and high metastatic ability from both NL and LNR fusions were examined for tumorigenicity and "experimental" metastatic ability in nude mice, as well as for expression of several genes thought to be involved in ras-induced progression and malignancy. Patterns of expression of these genes showed a relationship to level of malignancy of the hybrids and demonstrated a responsiveness to the expression of activated ras. These results suggest that the complementation of phenotype observed in the hybrids may arise through a gene regulatory factor(s) supplied by the NIH 3T3- to the LTA-derived parent.
Databáze: MEDLINE